1Tavaniotou A, Albano C, Smitz J, et al.Comparison of LH con centrations in the early and mid-luteal phase in IVF cycles aftertreatment with HMG alone or in association with the GnRH antagonist Cetrorelix[J].Hum Reprod,2001,16(4):663-667.
2Beckers NG, Laven JS, Eijkemans MJ, et al.Follicular and lute al phase characteristics following early cessation of gonadotro phin releasing hormone agonist during ovarian stimulation for in vitro fertilization[J]. Hum Reprod, 2000,15 ( 1 ); 43-49.
3Tarlatzis BC, Griesinger G, Leader A, Rombauts L, Ijzerman Boon PC, Mannaerts BM. Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH [J]. Reprod Biomed Online,2012,24(4):410-419.
4Al-Inany HG, Youssef MA, Aboulghar M, et al. Gonadotro phin-releasing hormone antagonists for assisted reproductive technology [J]. Cochrane Database Syst Rev, 2011, 11 ( 5 ) CD001750.
5Shemesh M, Mizrachi D, Gurevich M, et al.Expression of func- tional luteinizing hormone (LH) receptor and its messenger ri- bonueleic acid in bovine endometrium: LH augmentation of cAMP and inositol phosphate in vitro and human chorionic gonadotropin (hCG) augmentation of peripheral prostaglandin in vivo[J].Reprod Biol,2001,1(2) :13-32.
6Humaidan P,Kol S,Papanikolaou EG. GnRH agonist for trig gering of final oocyte maturation:time for a change of practice?[J]. Hum Reprod Update,2011,17(4) : 510-524.
7Humaidan P,Bredkjaer,Bungum L,et aI.GnRH agonist (Buse relin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomised study[J].Hura Re prod,2005 ,20(11):3258-3260,1213-1220.
8Humaidan P,Bungum L,Bungum M,et al.Rescue of corpus lu teum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was trig gered with a GnRH agonist: a pilot study[J].Reprod Biomed Online,2006,13(2) : 173-178.
9H urnaidan P, Ejdrup Bredkjaer H, Westergaard LG, et al. 1,500 IU human chorionic gonadotropin administered at ooeyte re trieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction:a prospective randomized, controlled study[J].Fertil Steril, 2010,93 (3) : 847- 854.
10Humaidan P, Van Vaerenbergh I, Bourgain C, et al. Endome- trial gene expression in the early [uteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimula- ted and GnRH antagonist co-treated IVF cycles[J].Hum Re-prod,2012 ,27(11):3259-3272.
